We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$585M
| $7.39K | ﹤0.01% |
226
| – | – |
|
|
ATSG
1627
DELISTED
Air Transport Services Group
ATSG
| $7.36K | ﹤0.01% |
+390
| New | +$7.25K |
|
1628
Amerant Bancorp
AMTB
$1.13B
| $7.34K | ﹤0.01% |
+427
| New | +$7.95K |
|
1629
Atlanta Braves Holdings Series B
BATRK
$3.22B
| $7.33K | ﹤0.01% |
185
| – | – |
|
1630
Fluor
FLR
$7.76B
| $7.31K | ﹤0.01% |
247
+16
| +7% | +$459 |
|
1631
Western Alliance Bancorporation
WAL
$8.78B
| $7.29K | ﹤0.01% |
200
+196
| +4,900% | +$6.8K |
|
1632
JELD-WEN Holding
JELD
$165M
| $7.28K | ﹤0.01% |
415
| – | – |
|
1633
Omega Flex
OFLX
$309M
| $7.26K | ﹤0.01% |
70
| – | – |
|
|
MDRX
1634
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.25K | ﹤0.01% |
575
+504
| +710% | +$6.12K |
|
1635
Intellia Therapeutics
NTLA
$1.68B
| $7.22K | ﹤0.01% |
177
+92
| +108% | +$3.73K |
|
1636
Ziff Davis
ZD
$2.03B
| $7.22K | ﹤0.01% |
103
-18
| -15% | -$1.23K |
|
1637
Norwegian Cruise Line
NCLH
$8.72B
| $7.18K | ﹤0.01% |
330
+152
| +85% | +$2.33K |
|
1638
AerCap
AER
$23.6B
| $7.18K | ﹤0.01% |
113
| – | – |
|
1639
Amkor Technology
AMKR
$13.6B
| $7.17K | ﹤0.01% |
241
| – | – |
|
1640
BioCryst Pharmaceuticals
BCRX
$2.45B
| $7.16K | ﹤0.01% |
1,017
+752
| +284% | +$6.04K |
|
1641
Emergent Biosolutions
EBS
$232M
| $7.14K | ﹤0.01% |
972
+867
| +826% | +$8.04K |
|
|
CFLT
1642
DELISTED
Confluent
CFLT
| $7.13K | ﹤0.01% |
202
+130
| +181% | +$3.64K |
|
1643
Seaboard Corp
SEB
$4.02B
| $7.12K | ﹤0.01% |
2
-2
| -50% | -$7.6K |
|
1644
Bank OZK
OZK
$5.6B
| $7.11K | ﹤0.01% |
177
+42
| +31% | +$1.51K |
|
1645
AGCO
AGCO
$7.1B
| $7.1K | ﹤0.01% |
54
-39
| -42% | -$4.84K |
|
1646
Scholastic
SCHL
$795M
| $7.04K | ﹤0.01% |
181
| – | – |
|
1647
Arbor Realty Trust
ABR
$979M
| $7.03K | ﹤0.01% |
474
+84
| +22% | +$1.04K |
|
1648
Brown & Brown
BRO
$23.7B
| $7.02K | ﹤0.01% |
102
+7
| +7% | +$445 |
|
1649
Titan International
TWI
$465M
| $7K | ﹤0.01% |
610
+394
| +182% | +$4.18K |
|
1650
Univest Financial
UVSP
$1.18B
| $6.98K | ﹤0.01% |
386
+235
| +156% | +$4.6K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.